Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier
BOCA RATON, Fla., May 8, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products with Premier. Effective August 1, 2019, the new agreement allows Premier members, at their discretion, to take advantage of special pricing […]
Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019
BOCA RATON, Fla., April 25, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter […]
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World’s First Sculptura™ Intraoperative Radiation Therapy System
Sculptura™ Provides Single Treatment During Surgery for Cancer Patients BOCA RATON, Fla., April 24, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, today announced that the Company has signed a research and development agreement with the Perelman School of Medicine at the University of […]
Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare’s Superficial Radio Therapy
Sensus’ SRT-100™ Indicates High Cure Rates in Long-Term Retrospective Study BOCA RATON, Fla., April 23, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological conditions, announced today topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radio […]
Sensus Healthcare to Present at the 31st Annual ROTH Conference
BOCA RATON, Fla., March 13, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19 at 3:30 p.m. […]
Sensus Healthcare Launches SRT University, an Online Portal to Support Physicians
New Online Portal System to Offer Training and Education Related to SRT Devices and Technology BOCA RATON, Fla., March 12, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today the launch of SRT University, an online portal to support […]
Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer
Medical Laser Pioneer and Veteran Entrepreneur Brings Over 30 Years of Experience to Company BOCA RATON, Fla., Feb. 28, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the Company has appointed Dr. Ziv Karni to the role […]
U.S. FDA Grants Market Clearance to Sensus Healthcare’s New Sculptura™ Radiation Oncology System
A Single Treatment during Surgery, Sculptura™ Eliminates Weeks of Post-Operative Radiation for Cancer Patients BOCA RATON, Fla., Feb. 26, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that the U.S. Food and Drug Administration (FDA) has granted market […]
Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth
Shipped 27 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radio Therapy to Treat Non-Melanoma Skin Cancers and Keloids
Published in The Journal of Clinical and Aesthetic Dermatology, Consensus was Reached that SRT is Safe, and Effective in Treating SCC and BCC and Should be Considered as the First-Line Form of Radiation Treatment. BOCA RATON, Fla., Feb. 14, 2019 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment […]
